Literature DB >> 33413696

N-acetylcysteine dose-dependently improves the analgesic effect of acetaminophen on the rat hot plate test.

Samaneh Nakhaee1, Mohammad Dastjerdi2, Hesam Roumi2, Omid Mehrpour1,3, Khadijeh Farrokhfall4.   

Abstract

BACKGROUND: Acetaminophen (APAP) induced hepatotoxicity is a clinically important problem. Up to now, interventive therapy with n-acetylcysteine (NAC) has been considered as a gold-standard treatment for APAP overdose. However, no study has focused on the efficacy of these drugs' concurrent administration on probable enhancing therapeutic outcomes. Thus, this study was aimed to investigate the analgesic effect of co-administration of NAC and acetaminophen in male rats. The NAC-APAP drug formulation may demonstrate the stranger antinociceptive effect.
METHODS: Forty-eight male Sprague-Dawley rats (12-14 weeks) randomly divided into six equal groups; control, APAP (received 300 mg/kg APAP), NAC (received 600 mg/kg NAC) and APAP+ NAC groups that received simultaneously 300 mg/kg APAP with 200-600 mg/kg NAC (AN200, AN400, AN600). All administrations were done orally for once. The antinociceptive effect was recorded by measurement of latency period on a hot plate in 30, 60, and 90 min after administrations.
RESULTS: The results showed that NAC's concurrent administration with APAP, dose-dependently increased APAP analgesic effects (p< 0.0001). Moreover, NAC treatment exhibited an antinociceptive effect in 60 and 90 min, per se. The treatments had no adverse effect on liver enzymes and oxidative stress.
CONCLUSION: Co-administration of NAC with APAP can improve the antinociceptive effect of APAP. It is suggested that this compound can enhance analgesic effects of APAP and eventually lead to a reduction in acetaminophen dose. Further studies are needed to evaluate the molecular mechanism of this hyper analgesic effect.

Entities:  

Keywords:  Acetaminophen; Analgesic effect; Co-administration; Hot plate; N-acetyl cysteine; Pain; Rat

Mesh:

Substances:

Year:  2021        PMID: 33413696      PMCID: PMC7791802          DOI: 10.1186/s40360-020-00469-4

Source DB:  PubMed          Journal:  BMC Pharmacol Toxicol        ISSN: 2050-6511            Impact factor:   2.483


  37 in total

1.  Effects of naloxone and flumazenil on antinociceptive action of acetaminophen in rats.

Authors:  Halit Madenoğlu; Mustafa Kaçmaz; Recep Aksu; Cihangir Bicer; Gülay Yaba; Karamehmet Yildiz; Kudret Doğru; Adem Boyaci
Journal:  Curr Ther Res Clin Exp       Date:  2010-04

2.  Suppression of amphiregulin/epidermal growth factor receptor signals contributes to the protective effects of quercetin in cirrhotic rats.

Authors:  María J Cuevas; Juliana Tieppo; Norma Possa Marroni; María J Tuñón; Javier González-Gallego
Journal:  J Nutr       Date:  2011-05-11       Impact factor: 4.798

3.  A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia.

Authors:  K Hargreaves; R Dubner; F Brown; C Flores; J Joris
Journal:  Pain       Date:  1988-01       Impact factor: 6.961

4.  Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3 receptors: in vivo and in vitro evidence.

Authors:  T Pelissier; A Alloui; F Caussade; C Dubray; A Cloarec; J Lavarenne; A Eschalier
Journal:  J Pharmacol Exp Ther       Date:  1996-07       Impact factor: 4.030

5.  Free radicals contribute to the reduction in peripheral vascular responses and the maintenance of thermal hyperalgesia in rats with chronic constriction injury.

Authors:  Zeinab Khalil; Tao Liu; Robert D Helme
Journal:  Pain       Date:  1999-01       Impact factor: 6.961

6.  Effect of N-acetylcysteine on the spinal-cord glutathione system and nitric-oxide metabolites in rats with neuropathic pain.

Authors:  Andréa Horst; Carolina Kolberg; Maira S Moraes; Ana Paula K Riffel; Isabela A Finamor; Adriane Belló-Klein; Maria Amália Pavanato; Wania A Partata
Journal:  Neurosci Lett       Date:  2014-04-03       Impact factor: 3.046

7.  Effects of N-acetylcysteine on spinal cord oxidative stress biomarkers in rats with neuropathic pain.

Authors:  A Horst; J A de Souza; M C Q Santos; A P K Riffel; C Kolberg; W A Partata
Journal:  Braz J Med Biol Res       Date:  2017-10-19       Impact factor: 2.590

8.  Antinociceptive and anti-inflammatory effects of N-acetylcysteine and verapamil in Wistar rats.

Authors:  Ahmed Abdullah Elberry; Souty Mouner Zaky Sharkawi; Mariam Rofaiel Wahba
Journal:  Korean J Pain       Date:  2019-10-01

9.  N-Acetyl-cysteine causes analgesia by reinforcing the endogenous activation of type-2 metabotropic glutamate receptors.

Authors:  Matteo Bernabucci; Serena Notartomaso; Cristina Zappulla; Francesco Fazio; Milena Cannella; Marta Motolese; Giuseppe Battaglia; Valeria Bruno; Roberto Gradini; Ferdinando Nicoletti
Journal:  Mol Pain       Date:  2012-10-23       Impact factor: 3.395

10.  Evaluating the Psychiatric Benefits of Formulating Acetaminophen With N-Acetylcysteine.

Authors:  Ryan Serdenes; James Graham
Journal:  Front Psychiatry       Date:  2020-10-23       Impact factor: 4.157

View more
  3 in total

1.  Hepatoprotective Effect of Oplopanax elatus Nakai Adventitious Roots Extract by Regulating CYP450 and PPAR Signaling Pathway.

Authors:  Xiao-Long Jiang; Pan-Yue Luo; Yan-Ying Zhou; Zhi-Hui Luo; Yue-Jun Hao; Ming-Zhi Fan; Xiao-Han Wu; Hao Gao; Hui-Chang Bi; Zhi-Bin Zhao; Mei-Lan Lian; Zhe-Xiong Lian
Journal:  Front Pharmacol       Date:  2022-05-02       Impact factor: 5.988

2.  Effect of red beetroot juice on oxidative status and islet insulin release in adult male rats.

Authors:  Armin Sayyar; Mohammad Oladi; Mehran Hosseini; Samaneh Nakhaee; Zomorrod Ataie; Khadijeh Farrokhfall
Journal:  Diabetol Metab Syndr       Date:  2022-04-23       Impact factor: 5.395

3.  The Effect of Cinnamaldehyde on iNOS Activity and NO-Induced Islet Insulin Secretion in High-Fat-Diet Rats.

Authors:  Zomorrod Ataie; Mohammad Dastjerdi; Khadijeh Farrokhfall; Zahra Ghiravani
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-13       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.